Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease.
about
Anxiety, depression, coronary artery disease and diabetes mellitus; an association study in ghaem hospital, iranBarberry administration and pro-oxidant-antioxidant balance in patients with metabolic syndrome.Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients.Comparison of Novel Coronary Artery Disease Risk Factors between Obese and Normal AdolescentSaffron supplements modulate serum pro-oxidant-antioxidant balance in patients with metabolic syndrome: A randomized, placebo-controlled clinical trial.Prooxidant-Antioxidant Balance in Patients with Systemic Lupus Erythematosus and Its Relationship with Clinical and Laboratory Findings.MnSOD and GPx1 polymorphism relationship with coronary heart disease risk and severity.Evaluation of oxidant-antioxidant balance and total antioxidant capacity of serum in children with urinary tract infectionCoronary artery disease and its risk factors status in iran: a review.Low paraoxonase 1 activity predicts mortality in surgical patients with sepsis.The Effects of Curcumin and Curcumin-Phospholipid Complex on the Serum Pro-oxidant-Antioxidant Balance in Subjects with Metabolic Syndrome.Does at-home bleaching induce systemic oxidative stress in healthy subjects?In-vitro Evaluation of Protective Effects on DNA Damage and Antioxidative Activities of Ilex Spinigera Loes. Extracts.The Effects of Panax Ginseng on Lipid Profile, Pro-oxidant: Antioxidant Status and High-sensitivity C Reactive Protein Levels in Hyperlipidemic Patients in Iran.Prooxidant-antioxidant balance in umbilical cord blood of infants with meconium stained of amniotic fluid.Evaluation of prooxidant-antioxidant balance in chronic heroin users in a single assay: an identification criterion for antioxidant supplementation.Hyperlipidemia, oxidative stress, and intima media thickness in children with chronic kidney disease.Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals.Pro-oxidant-antioxidant balance in Iranian veterans with sulfur mustard toxicity and different levels of pulmonary disorders.Total antioxidant status and markers of oxidative stress in subjects with normal or impaired glucose regulation (IFG, IGT) in diabetic patients.Ischemia-modified albumin and advanced oxidation protein products as potential biomarkers of protein oxidation in Alzheimer's disease.Prooxidant-antioxidant balance in patients with traumatic brain injury.Prooxidant-antioxidant balance, advanced oxidation protein products and lipid peroxidation in Serbian patients with Parkinson's disease.Associations of oxidative stress status parameters with traditional cardiovascular disease risk factors in patients with schizophrenia.Serum zinc and copper status in Iranian patients with pemphigus vulgaris.The impact of protein oxidation on sustained and white coat hypertension.Fluoxetine ameliorates imbalance of redox homeostasis and inflammation in an acute kidney injury model.The role of protein oxidation and DNA damage in elderly hypertension.Prooxidant-antioxidant balance and risk factors of coronary artery disease.Evaluation of prooxidant-antioxidant balance in in vitro fertilization-conceived mice.Anti-Heat Shock Protein 27 Titers and Oxidative Stress Levels are Elevated in Patients With Valvular Heart DiseaseProoxidant-Antioxidant Balance and Antioxidized LDL Antibody Level Values and Cardiac Function in Patients with Coronary Artery Disease
P2860
Q34733727-D4DFCEB0-6D49-4A6A-BECC-AC698270C2D9Q35123953-5D8B3520-6706-477F-B1E3-088B202CB1D9Q35226805-3DD325CE-B3F6-4C82-B424-191CA41A389AQ35804912-069812EB-01F1-4934-A23F-AB4A9891477AQ36140230-CEE676ED-6D65-430D-AF56-86783168B08FQ36559061-2BFB7B9F-1414-45D9-B374-17EA13AD889EQ36790505-301D68DC-5931-4C0E-96B0-2B84B0544CB2Q36915608-1D58529B-275C-4D7B-BA14-C4557F45C3CBQ37188328-37E4E7DE-E7E3-4281-8AD2-0BF0BA8C776FQ37601977-02D68FF1-55D0-468A-8A95-5617601E0521Q38608648-008A45B6-2BB1-401D-887E-95259F6FC089Q39841427-88D16C91-F506-471A-8EB8-70880D8F035DQ41858254-3BA89990-21EC-485D-B421-9D1E17D9D324Q42105852-ED66EF25-4E64-42A0-AA5B-42A9D3FB4009Q42793854-02D79788-2732-4B3C-A94A-CC163E0FBAA8Q43013042-02B7F741-6199-4317-B42F-002E23997EA9Q44121418-15403B36-70FC-48D3-A99B-EBA2985FBDBFQ44314740-989F4A7F-C179-4FCF-9198-B34E895E9AB6Q45327809-0E590DC3-942D-4FA8-B53D-605DD3280600Q46060210-BE2B8460-7E62-4B39-959C-9DCC2C71C613Q46821561-5D303ABA-A648-46B6-BF1E-D92D505A4026Q46866335-DFC073C7-ACBA-4CF2-82C4-B5673AF68414Q47392210-DCFC96FF-3CEF-4233-B2CC-4996B1712397Q51328235-B99B56A7-8B09-44AD-A7A8-914871547D6CQ51401171-2FFFCCEF-160B-49D7-B414-D86D0AC34204Q51449756-3907DC85-F000-4B82-A40C-9E240104B428Q52654051-9A92ECAF-D611-4DFC-A64B-E8B148E8719CQ53662116-165BB290-AC66-4ECC-8CE9-9A267AA59D92Q54577335-F6BB13B1-C7B8-4198-9F5C-A08D7026069AQ55447025-B10CE339-9401-4DD5-B14F-B338C0B0A24AQ57892478-45E916F8-C152-4A33-9734-CF32D2A9B5E8Q57892534-37251AEE-2C35-4F72-BF6B-0AF83DDDEB32
P2860
Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Prooxidant-antioxidant balance ...... fined coronary artery disease.
@en
Prooxidant-antioxidant balance ...... fined coronary artery disease.
@nl
type
label
Prooxidant-antioxidant balance ...... fined coronary artery disease.
@en
Prooxidant-antioxidant balance ...... fined coronary artery disease.
@nl
prefLabel
Prooxidant-antioxidant balance ...... fined coronary artery disease.
@en
Prooxidant-antioxidant balance ...... fined coronary artery disease.
@nl
P2093
P921
P1476
Prooxidant-antioxidant balance ...... efined coronary artery disease
@en
P2093
Daryoush Hamidi Alamdari
Fahimeh Ghafoori
George Koliakos
Konstantinos Paletas
Majid Ghayour-Mobarhan
Mohammad Reza Parizadeh
Mohsen Moohebati
Shima Tavallaie
Theodosia Pegiou
P304
P356
10.1016/J.CLINBIOCHEM.2007.12.008
P577
2007-12-27T00:00:00Z